Kayıkçıoglu, E. and Findos, E. 2022. The prognostic immune nutritional index is a predictive biomarker in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide: Prognostic immune nutritional index and prostate adenocancer. The Injector. 1, 3 (Nov. 2022), 106–114. DOI:https://doi.org/10.5281/zenodo.7331456.